Market Place
Sourcing Support
GSK launches once daily, single inhaler-triple therapy for COPD patients
26 Apr 2022 //
ECONOMICTIMES
CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD Ellipta
01 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
FDA Approvals Roundup: Detectnet, Nityr, Trelegy Ellipta
16 Sep 2020 //
RAPS
GSK books 19% sales growth for first quarter
29 Apr 2020 //
PHARMATIMES
GSK filing accepted by European Medicines Agency for Trelegy Ellipta
27 Feb 2020 //
PRESS RELEASE
GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
03 Oct 2019 //
BUSINESSWIRE
AstraZeneca respiratory business gets boost from 3-drug inhaler results
29 Aug 2019 //
REUTERS
AstraZeneca’s COPD triplet Breztri nabs first nod from Japan
20 Jun 2019 //
FIERCE PHARMA
Teva closes in on $3B cost-cutting goal
02 May 2019 //
FIERCE PHARMA
Theravance Biopharma Expanded COPD Indication for Trelegy Ellipta in Europe
12 Nov 2018 //
PR NEWSWIRE
EU expands label of GSK/Innoviva’s COPD inhaler
12 Nov 2018 //
PHARMA TIMES
GlaxoSmithKline`s Shingrix zooms toward blockbuster status despite tight supply
31 Oct 2018 //
FIERCE PHARMA
AZ rival to GSK’s COPD drug Anoro fails head-to-head test
24 Aug 2018 //
PMLIVE
Hit by surprise setback, AZ explains why inhaler beaten by GSK rival
23 Aug 2018 //
ENDPTS
GlaxoSmithKline is plotting a $525M cost-cutting drive instead of Spin-off
26 Jul 2018 //
FIERCE PHARMA
GSK submits regulatory application in Japan for once-daily single inhaler
29 May 2018 //
PRESS RELEASE
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment
24 Apr 2018 //
PRESS RELEASE
GSK’s Anoro Ellipta beats BI’s Spiolto Respimat in COPD trial
02 Nov 2017 //
PHARMA TIMES
GSK closes in on EU approval for triple COPD therapy
18 Sep 2017 //
PMLIVE
CHMP backs 13 treatments for EU approval
18 Sep 2017 //
PHARMA TIMES
GSK`s three-in-one inhaler gets positive opinion from EU agency
15 Sep 2017 //
REUTERS
EMA committee recommends approval of once-daily single inhaler triple therapy
15 Sep 2017 //
PHARMABIZ
GlaxoSmithKline opens new $56.6M vaccines plant in Scotland
15 Aug 2017 //
FIERCE PHARMA
GSK moves forward with new plant in Scotland for Ventolin API
28 Feb 2017 //
FIERCE PHARMA
Eight medicines leap towards EU approval
30 Jan 2017 //
PHARMATIMES
GSK begins phIII study of once-daily closed triple combo therapy FF/UMEC/VI
19 Dec 2016 //
PHARMABIZ
GSK files triple combo for COPD in Europe
05 Dec 2016 //
PHARMATIMES
Mereo BioPharma appoints CFO
21 Nov 2016 //
PMLIVE
GSK`s Bexsero Vaccine Growing Fast, Despite "Tight" Supply
28 Oct 2016 //
PMLIVE
GSK`s triple COPD therapy tops Symbicort in phase III trial
21 Jun 2016 //
PMLIVE
How Will GlaxoSmithKline`s Triple Therapy Combination Perform In The Market?
27 Jan 2016 //
SEEKING ALPHA
Anvisa approves novel medicines for kidney cancer and lung disease
16 Dec 2015 //
ANVISA
Boehringer trumpets Spiolto quality-of-life data as it looks for its niche in COPD
19 Aug 2015 //
FIERCE PHARMA
Prescription for Glaxo: A New Boss?
05 May 2015 //
BLOOMBERG BUSINESS
Japanese MHLW Approves GSK`s Encruse Ellipta For COPD Treatments
28 Mar 2015 //
PHARMABIZ
Glaxo Sees Hope for Respiratory Drugs as Earnings Beat Estimates
04 Feb 2015 //
BLOOMBERG
GSK Expands its Portfolio of Medicines in the US for Patients with Asthma and COPD
26 Jan 2015 //
PR NEWSWIRE
